Page last updated: 2024-09-04

pomalidomide and B16 Melanoma

pomalidomide has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edil, BH; Fujiwara, Y; He, J; Schulick, RD; Sun, Y; Torphy, RJ; Yanaga, K; Zhu, Y1
Bartlett, JB; Chen, RS; Hariri, RJ; Hughes, CC; Lu, L; Man, HW; Muller, GW; Payvandi, F; Schafer, PH; Stirling, DI; Wu, L; Zhang, LH1

Other Studies

2 other study(ies) available for pomalidomide and B16 Melanoma

ArticleYear
Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity.
    Cancer research, 2018, 12-01, Volume: 78, Issue:23

    Topics: Animals; Antineoplastic Agents; B7-H1 Antigen; Cell Line, Tumor; Cytotoxicity, Immunologic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunity; Immunologic Factors; Immunomodulation; Melanoma, Experimental; Mice; Neoplasms; T-Lymphocyte Subsets; Thalidomide

2018
The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions.
    Microvascular research, 2009, Volume: 77, Issue:2

    Topics: Adherens Junctions; Angiogenesis Inhibitors; Animals; Antigens, CD; Antineoplastic Agents; Basic Helix-Loop-Helix Transcription Factors; beta Catenin; Cadherins; Cell Differentiation; Cell Hypoxia; Cell Line, Tumor; Cells, Cultured; Endothelial Cells; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; In Vitro Techniques; Lenalidomide; Lung Neoplasms; Melanoma, Experimental; Mice; Microcirculation; Neoplasm Metastasis; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Pregnancy; Proto-Oncogene Proteins c-akt; Thalidomide; Umbilical Arteries

2009